{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:55:26Z","timestamp":1761310526263},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1626,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.11.094","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T13:28:10Z","timestamp":1229520490000},"page":"1080-1086","source":"Crossref","is-referenced-by-count":38,"title":["A prime\/boost DNA\/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis"],"prefix":"10.1016","volume":"27","author":[{"given":"Connor","family":"Carson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Bego\u00f1a","family":"Ruiz-Arg\u00fcello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Alcami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippokratis","family":"Messaritakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenefer M.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orin","family":"Courtenay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2008.11.094_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0169-4758(00)01637-9","article-title":"The strange case of Leishmania chagasi","volume":"16","author":"Mauricio","year":"2000","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2008.11.094_bib2","unstructured":"WHO\/TDR. http:\/\/www.who.int\/tdr\/diseases\/leish\/direction.htm, 2002."},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.094_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.094_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2006.05.001","article-title":"Leishmune\u00ae vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine","volume":"141","author":"Dantas-Torres","year":"2006","journal-title":"Vet Parasitol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2008.11.094_bib6","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.11.094_bib7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.11.094_bib8","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.094_bib9","doi-asserted-by":"crossref","unstructured":"Dumonteil E. DNA vaccines against protozoan parasites: Advances and challenges. J Biomed Biotechnol 2007; Article 90520.","DOI":"10.1155\/2007\/90520"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0166-6851(95)02569-3","article-title":"An expressed sequence tag analysis of a full-length, spliced-leader cDNA library from Leishmania major promastigotes","volume":"76","author":"Levick","year":"1996","journal-title":"Mol Biochem Parasit"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0166-6851(98)00122-4","article-title":"Identification and characterisation of a functional peroxidoxin from Leishmania major","volume":"96","author":"Levick","year":"1998","journal-title":"Mol Biochem Parasit"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.094_bib12","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect Immun"},{"issue":"1417","key":"10.1016\/j.vaccine.2008.11.094_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1098\/rstb.2001.0985","article-title":"From genomes to vaccines: Leishmania as a model","volume":"357","author":"Almeida","year":"2002","journal-title":"Philos T Roy Soc B"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.094_bib14","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.11.094_bib15","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.vaccine.2008.11.094_bib16","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.vaccine.2005.08.048","article-title":"Synergistic DNA\u2013MVA prime\u2013boost vaccination regimes for malaria and tuberculosis","volume":"24","author":"Gilbert","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.094_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/IAI.01490-06","article-title":"Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB\/c Mice","volume":"75","author":"Stober","year":"2007","journal-title":"Infect Immun"},{"issue":"6736","key":"10.1016\/j.vaccine.2008.11.094_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/21208","article-title":"Modelling T-cell memory by genetic marking of memory T cells in vivo","volume":"399","author":"Jacob","year":"1999","journal-title":"Nature"},{"issue":"5210","key":"10.1016\/j.vaccine.2008.11.094_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2008.11.094_bib20","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime\u2013boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.094_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime\u2013boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.094_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.11.094_bib23","first-page":"225","article-title":"Vaccination against pox diseases under immunosuppressive conditions","volume":"41","author":"Mayr","year":"1978","journal-title":"Dev Biol Stand"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.094_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00262-004-0616-7","article-title":"A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)","volume":"54","author":"Meyer","year":"2005","journal-title":"Cancer Immunol Immun"},{"issue":"15","key":"10.1016\/j.vaccine.2008.11.094_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0264-410X(02)00076-2","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"20","author":"Amara","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.11.094_bib26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/378515","article-title":"Safety and immunogenicity of DNA\/modified vaccinia virus ankara malaria vaccination in african adults","volume":"188","author":"Moorthy","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.094_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus ankara prime\u2013boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.094_bib28","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.4049\/jimmunol.168.9.4391","article-title":"Competition between CTL narrows the immune response induced by prime\u2013boost vaccination protocols","volume":"168","author":"Palmowski","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.094_bib29","unstructured":"Gradoni L, Gramiccia M. Leishmaniosis. In: OIE manual of standards for diagnostic tests and vaccines for terrestrial animals. 4th ed. Paris, France, Office International des Epizooties, 2004: 803\u201312."},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.094_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S0031182097001200","article-title":"The epidemiology of canine leishmaniasis: Transmission rates estimated from a cohort study in Amazonian Brazil","volume":"115","author":"Quinnell","year":"1997","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.094_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.actatropica.2004.09.007","article-title":"First detection of Leishmania major in peridomestic Phlebotomus papatasi from Isfahan province, Iran: Comparison of nested PCR of nuclear ITS ribosomal DNA and semi-nested PCR of minicircle kinetoplast DNA","volume":"93","author":"Parvizi","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2008.11.094_bib32","unstructured":"UK Home Office. Code of practice for the housing and care of animals used in scientific procedures (1989). http:\/\/scienceandresearch.homeoffice.gov.uk\/animal-research."},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.094_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2915.2000.00237.x","article-title":"Sampling methods for phlebotomine sandflies","volume":"14","author":"Alexander","year":"2000","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.vaccine.2008.11.094_bib34","unstructured":"European Medicines Agency: Evaluation of the safety of veterinary medicinal products for the target animals. 7AE2a 1994; vol. 7."},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.094_bib35","first-page":"687","article-title":"Comparison of whole-blood and purified canine lymphocytes in a lymphocyte-stimulation microassay","volume":"39","author":"Shifrine","year":"1978","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2008.11.094_bib36","series-title":"Practice and theory of enzyme immunoassays","author":"Tijssen","year":"1985"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.094_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune-responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.094_bib38","series-title":"DNA Cloning: A Practical Approach","first-page":"191","article-title":"The construction and characterization of vaccinia virus recombinants expressing foreign genes","author":"Mackett","year":"1985"},{"key":"10.1016\/j.vaccine.2008.11.094_bib39","unstructured":"European Medicines Agency: Specific requirements for the production and control of live and inactivated viral and bacterial vaccines for cats and dogs 7BIm13a 1995; vol. 7."},{"key":"10.1016\/j.vaccine.2008.11.094_bib40","unstructured":"European Commission: Directive 86\/609\/EEC on the protection of animals used for experimental and other scientific purposes (1986). http:\/\/ec.europa.eu\/environment\/chemicals\/lab_animals\/home_en.htm."},{"issue":"8","key":"10.1016\/j.vaccine.2008.11.094_bib41","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.094_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","article-title":"Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis","volume":"26","author":"Ferreira","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.094_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathogenesis"},{"issue":"22","key":"10.1016\/j.vaccine.2008.11.094_bib44","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.11.094_bib45","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T-Cell lines derived from asymptomatic dogs that lyse infected macrophages in a Major Histocompatibility Complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"28","key":"10.1016\/j.vaccine.2008.11.094_bib46","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.11.094_bib47","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2008.11.094_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet Res"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetpar.2007.03.037","article-title":"Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation","volume":"147","author":"Day","year":"2007","journal-title":"Veterinary Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.094_bib50","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.094_bib51","first-page":"33","article-title":"Lessons from Leishmania\u2014a model for investigations of Cd4+ subset differentiation","volume":"1","author":"Reiner","year":"1992","journal-title":"Infect Agent Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.094_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.094_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.11.094_bib54","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1128\/IAI.73.6.3787-3789.2005","article-title":"Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses","volume":"73","author":"Pinheiro","year":"2005","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.094_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(02)00134-4","article-title":"Cytokine expression during the outcome of canine experimental infection by Leishmania infantum","volume":"88","author":"Santos-Gomes","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.094_bib57","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/319869","article-title":"Tissue cytokine responses in canine visceral leishmaniasis","volume":"183","author":"Quinnell","year":"2001","journal-title":"J Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2008.11.094_bib58","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Goto","year":"2007","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2008.11.094_bib59","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:48:47Z","timestamp":1684802927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08016551"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}